# Viral Specific T-cells for Treatment of COVID-19

> **NCT04406064** · PHASE2 · WITHDRAWN · sponsor: **Children's Hospital Medical Center, Cincinnati**

## Conditions studied

- Viral Infection

## Interventions

- **BIOLOGICAL:** Viral Specific T-cells (VSTs)

## Key facts

- **NCT ID:** NCT04406064
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-01
- **Primary completion:** 2024-06
- **Final completion:** 2025-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The use of steroids to treat COVID prevents the use of VSTs for these patients. The Principal Investigator does not feel the study had an expectation of enrolling patients as the treatment options for COVID have evolved.
- **Last updated:** 2021-01-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04406064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04406064, "Viral Specific T-cells for Treatment of COVID-19". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04406064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*